View the week's key company earnings schedule and key stories to watch.
The top 5 stories to look out for (4-10 April 2016)
1. TUE 5 APR
Just what the doctor ordered for Walgreens Boots & Rite Aid?
Earnings from US pharmacies will generate interest as Walgreens looks to merge with Rite Aid after recently acquiring Britain’s Boots.
2. TUE 5 APR
AA hits the road with latest earnings report
Roadside recovery firm AA's shares have lost almost a third in the past year. Full-year earnings are forecast to fall but positive guidance could rescue its share price.
Monsanto Q2 earnings
Slumping sales are unlikely to see a turnaround for Monsanto shares as Swiss agrochemicals rival Syngenta pursues merger talks with government-backed ChemChina.
4. THU 7 APR
Simply good news for M&S ahead of Q4 sales update?
Can new boss Steve Rowe push M&S back to the top of the retail pile, or will the firm join rivals Next and H&M in their 2016 retail outlook warnings?
More trouble for oil explorer Rockhopper ahead of full-year earnings?
After plunging oil prices, Rockhopper Exploration may now have to contend with a UN ruling that Argentina’s maritime territorial waters now include the Falklands Islands.
Key company earnings (4-8 Apr)
Plexus Holdings (UK) - half-year
AA (UK) - full-year
International Consolidated Airlines Group SA (UK) - sales release
Card Factory (UK) - full-year
Darden Restaurants (US) - Q3
Electrocomponents (UK) - Q4
Walgreens Boots Alliance (US) - Q2
Acuity Brands (US) - Q2
Amerisur Resources (UK) - full-year
Bed Bath & Beyond (US) - Q4
Constellation Brands (US) - Q4
Global Payments (US) - Q3
Monsanto (US) - Q2
SunEdison (US) - Q4
Topps Tiles (UK) - Q2
CarMax (US) - Q4
ConAgra Foods (US) - Q3
Costco Wholesale - (US) - sales release
Dunelm Group (UK) - sales release
Gap (UK) - sales release
Marks & Spencer (UK) - trading update
Rite Aid (US) - Q4
Stolt-Nielson (UK) - Q1
Victrex (UK) - half-year
Rockhopper Exploration (UK) - full-year
Xcite Energy (UK) - Q4
Company announcements are subject to change. All the events listed above were correct at the time of writing.
CMC Markets is an execution-only service provider. The material (whether or not it states any opinions) is for general information purposes only, and does not take into account your personal circumstances or objectives. Nothing in this material is (or should be considered to be) financial, investment or other advice on which reliance should be placed. No opinion given in the material constitutes a recommendation by CMC Markets or the author that any particular investment, security, transaction or investment strategy is suitable for any specific person.